Clorgyline (BioCAD00000008697)

blood plant natural products

Metabolite Card

Formula: C13H15Cl2NO (271.0531)
SMILES: CN(CCCOC1=CC=C(Cl)C=C1Cl)CC#C

Synonyms [en]

Clorgyline; Clorgiline; Clorgilinum; Clorgilina; N-(3-(2,4-Dichlorophenoxy)propyl)-N-methyl-2-propynylamine; M&B 9302

Reviewed

Last reviewed on 2024-06-28.

Cite this Page

Clorgyline. 数据之源,洞见之始. SMRUCC genomics institute, a synthetic life researcher from China. https://biocad_registry.innovation.ac.cn/s/(-)-arctiin (retrieved 2026-01-03) (CAD Registry RN: BioCAD00000008697). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).

Note

An aromatic ether that is the 2,4-dichlorophenyl ether of 3-aminopropan-1-ol in which the nitrogen is substituted by a methyl group and a prop-1-yn-3-yl group. A monoamine oxidase inhibitor, it was formerly used as an antidepressant." []

Entity Information

DBLinks

Other DBLinks
  • CAS Registry Number: 17780-72-2
  • CAS Registry Number: 17780-75-5
  • PubChem: 4380
  • ChEBI: ChEBI:3763
  • HMDB: HMDB0250365
  • KEGG: C11685
  • BioCyc: CPD-7656
  • NCBI MeSH: Clorgyline
  • Wikipedia: Clorgiline
  • DrugBank: DB04017
  • RefMet: RM0036964
  • Metlin: METLIN_69153
  • Coconut NaturalProduct: CNP0111714.0

Class / Ontology

Metabolic Network
ID EC Number Name
View More
Organism Source

Taxonomy Source

  1. Elaphoglossum paleaceum [ncbi taxid: 264348]
  2. Psychotria nemorosa [ncbi taxid: 2072284]
  3. Sophora flavescens [ncbi taxid: 49840]

Pathway Synthetic

pathway id name
BioCyc:META_PWY-6307 L-tryptophan degradation X (mammalian, via tryptamine)
BioCyc:META_PWY6666-2 dopamine degradation
BioCyc:META_PWY-6071 superpathway of phenylethylamine degradation
BioCyc:ECO_2PHENDEG-PWY phenylethylamine degradation I
BioCyc:META_2PHENDEG-PWY phenylethylamine degradation I
BioCyc:META_PWY-6399 melatonin degradation II
BioCyc:ECO_PWY-6071 superpathway of phenylethylamine degradation
BioCyc:HUMAN_PWY6666-2 dopamine degradation
BioCyc:META_PWY-6402 superpathway of melatonin degradation
View All Pathways